Sergio Dias da Costa Junior
Overview
Explore the profile of Sergio Dias da Costa Junior including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
23
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Silva R, Rocha I, Dantas T, Dos Santos Silva J, Costa Junior S, Luz A, et al.
Microb Pathog
. 2024 Oct;
197:107078.
PMID: 39447661
The COVID-19 pandemic has raised concerns beyond the viral infection itself. Bacterial co-infections, particularly those involving Acinetobacter baumannii, have become a significant worry in critically ill COVID-19 patients. A. baumannii...
2.
Almeida Campos L, Costa Junior S, Santos J, Souza Z, da Silva C, Cristovao-Silva A, et al.
Microb Pathog
. 2024 Oct;
196:107007.
PMID: 39395747
The present study aimed to evaluate the anti-staphylococcal, antibiofilm, cytotoxicity and trypanocidal activity, mechanisms of parasite death and immunomodulatory effect of CrataBL encapsulated into liposomes (CrataBL-Lipo). CrataBL-Lipo were prepared by...
3.
de Souza J, de Lacerda Coriolano D, Dos Santos Silva R, Costa Junior S, Almeida Campos L, Cavalcanti I, et al.
Pharmaceuticals (Basel)
. 2024 Jun;
17(6).
PMID: 38931469
has been associated with the induction of colorectal cancer (CRC). Thus, combined therapy incorporating usnic acid (UA) and antibiotics such as ceftazidime (CAZ), co-encapsulated in liposomes, could be an alternative....
4.
Santos J, Costa Junior S, Dos Santos Medeiros S, Cavalcanti I, de Souza J, Coriolano D, et al.
Curr Microbiol
. 2022 Apr;
79(6):175.
PMID: 35488983
Antimicrobial resistance (AMR) represents a critical obstacle to public health worldwide, due to the high incidence of strains resistant to available antibiotic therapies. In recent years, there has been a...
5.
Costa Junior S, da Silva W, da Silva A, Maciel M, Cavalcanti I
Evid Based Complement Alternat Med
. 2020 Aug;
2020:9852145.
PMID: 32849907
The present study aimed to characterize the susceptibility profile of and spp. clinical isolates to polymyxin B in a public hospital in Recife-PE, Brazil, between the years of 2018 and...